Alphamab Oncology(HK:9966)
HK$6.15-0.09 (-1.52%)
HK:9966
Alphamab Oncology ownership
HK$6.15
At close:-0.09 (-1.52%)
Want to see HK:9966 full AI Analyst Report?
Alphamab Oncology (9966) Ownership - Who Owns Alphamab Oncology?
2 Followers
Alphamab Oncology (9966) Ownership Overview
- 1.71% Mutual Funds
- 2.59% ETFs
- 95.70% Public Companies and Individual Investors
The ownership structure of Alphamab Oncology (HK:9966) stock is a mix of institutional, retail, and individual investors. Approximately 4.30% of the company’s stock is owned by Institutional Investors, and 95.70% is owned by Public Companies and Individual Investors.
The ownership structure of Alphamab Oncology (HK:9966) stock is a mix of institutional, retail, and individual investors. Approximately 4.30% of the company’s stock is owned by Institutional Investors, and 95.70% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 16,467,959 | Institution | 1.69% | 13,124,963 |
| Vanguard International Equity Index Funds | 9,043,000 | Institution | 0.93% | 7,207,271 |
| Ishares | 7,715,000 | Institution | 0.79% | 6,148,855 |
| Vanguard Star Funds | 7,066,959 | Institution | 0.73% | 5,632,366 |
| State Street | 451,000 | Institution | 0.05% | 359,447 |
| Dimensional | 317,000 | Institution | 0.03% | 252,649 |
| Fidelity Salem Street Trust | 316,000 | Institution | 0.03% | 251,852 |
| Spdr | 205,000 | Institution | 0.02% | 163,385 |
| State Street Institutional Investment Trust | 121,000 | Institution | 0.01% | 96,437 |
| Dfa Investment Dimensions Group Inc | 117,000 | Institution | 0.01% | 93,249 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard International Equity Index Funds | 9,043,000 | Institution | 0.93% | 7,207,271 |
| Vanguard Star Funds | 7,066,959 | Institution | 0.73% | 5,632,366 |
| Fidelity Salem Street Trust | 316,000 | Institution | 0.03% | 251,852 |
| State Street Institutional Investment Trust | 121,000 | Institution | 0.01% | 96,437 |
| Dfa Investment Dimensions Group Inc | 117,000 | Institution | 0.01% | 93,249 |
| Sei Institutional Investments Trust | 29,000 | Institution | <0.01% | 23,113 |
| Franklin Alternative Strategies Funds | 1 | Institution | 0.00% | 1 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Total International Stock ETF, VXUS ETF | 7,202,959 | Institution | 0.74% | 7,704,462 |
| Vanguard FTSE Emerging Markets ETF, VWO ETF | 6,886,000 | Institution | 0.71% | 7,365,435 |
| iShares Core MSCI Emerging Markets ETF, IEMG ETF | 2,687,000 | Institution | 0.28% | 2,152,949 |
| Vanguard FTSE All-World ex-US Small-Cap ETF, VSS ETF | 1,844,000 | Institution | 0.19% | 1,972,386 |
| Vanguard Total World Stock ETF, VT ETF | 413,000 | Institution | 0.04% | 441,755 |
| SPDR S&P Emerging Markets Small Cap ETF, EWX ETF | 321,000 | Institution | 0.03% | 272,452 |
| Dimensional Emerging Markets Core Equity 2 ETF, DFEM ETF | 291,000 | Institution | 0.03% | 232,136 |
| iShares MSCI EM IMI ESG Screened UCITS ETF, GB:SEDM ETF | 251,000 | Institution | 0.03% | 213,039 |
| iShares MSCI China Small-Cap ETF, ECNS ETF | 195,000 | Institution | 0.02% | 156,243 |
| SPDR EM Sma Cap Accum.Shs Exchage Traded Fund USD, GB:EMSM ETF | 161,000 | Institution | 0.02% | 136,650 |
FAQ
What percentage of Alphamab Oncology (HK:9966) stock is held by institutional investors?
According to the latest TipRanks data, approximately 4.30% of Alphamab Oncology (HK:9966) stock is held by institutional investors: 1.71% by mutual funds and 2.59% by ETFs.
What percentage of Alphamab Oncology (HK:9966) stock is held by retail investors?
According to the latest TipRanks data, approximately 95.70% of Alphamab Oncology (HK:9966) stock is held by public companies and individual investors.
Who owns the most shares of Alphamab Oncology (HK:9966)?
Vanguard owns the most shares of Alphamab Oncology (HK:9966).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
